Cilia are minute hair-like structures present on the surface of respiratory mucosa. Each of these cilia beat continuously at 10–18 Hz, and this beating creates a constant flow of periciliary fluid, ...
Cilia are minute hair-like structures on the respiratory mucosa, which beat continuously at 10–18 Hz, and create a constant flow of periciliary fluid maintaining the sterility of the lower respiratory ...
Primary ciliary dyskenisia (PCD) is a rare genetic disease that causes the tiny hair-like filtration structures in the respiratory tract to stop working. As a result, the lungs accumulate thick mucus ...
Please provide your email address to receive an email when new articles are posted on . Ciliary beat frequency in neonates with mild bronchopulmonary dysplasia (BPD) significantly differed vs.
Please provide your email address to receive an email when new articles are posted on . Both percent-predicted FEV 1 and FVC in primary ciliary dyskinesia improved with the addition of idrevloride to ...
The researchers' findings, reported in Nature Structural & Molecular Biology, which involve radial spoke 3 (RS3), help answer some fundamental questions about how motile cilia work and could ...
Primary ciliary dyskenisia (PCD) is a rare genetic disease that causes the tiny hair-like filtration structures in the respiratory tract to stop working. As a result, the lungs accumulate thick mucus ...
MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--ReCode Therapeutics, a biopharmaceutical company powering the next wave of genetic medicines through superior delivery today presented new preclinical ...
MILAN -- Research presented at this year's annual European Respiratory Society congress included early successes in transplanting a patient's own lung cells to ease chronic obstructive pulmonary ...
THE purpose of the experimental work reported in this manuscript is to demonstrate a possible mechanism whereby tar and other combustion products in cigarette smoke might be deposited in the lower ...
MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, ...
A recent review provides insight into the clinical progression of treatment-naive patients with spinal muscular atrophy type 3 who have lost ambulation. Patients with spinal muscular atrophy (SMA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results